Showing 2731-2740 of 9928 results for "".
Galderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoDefining the Physician-Patient Relationship
https://practicaldermatology.com/topics/practice-management/defining-the-physician-patient-relationship/18928/In this edition of Derm Insider, Allan Wirtzer, MD and Cliff Lober, MD, JD talk to host Neal Bhatia, MD about the importance of defining the physician-patient relationship, determining when the relationship is established, and understanding the legal implications that come with that fiduciary or hei2020 Financial Benchmark Report: How Dermatology and Aesthetic Practices Fared in the COVID Era
https://practicaldermatology.com/topics/practice-management/2020-financial-benchmark-report-how-dermatology-and-aesthetic-practices-fared-in-the-covid-era/23693/How did your practice’s performance and growth compare to the rest of the industry?Hydroquinone in 2021
https://practicaldermatology.com/topics/pigmentary-disorders/hydroquinone-in-2021/23592/A year after OTC hydroquinone was pulled from the market as part of the CARES Act, a dermatologist discusses the effects on patient care.JAK Inhibitors in Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/jak-inhibitors-vitiligo-treatment/24559/Dr. Ted Lain, a dermatologist practicing in Austin, Texas, talks with Practical Dermatology about the latest developments and the promise of Janus kinase (JAK) inhibitors for the treatment of vitiligo. Dr. Lain covers the current impact of JAK inhibitors, their mechanism of action, how he's using thDonate Against East Coast Bias
https://practicaldermatology.com/columns/editors-message/donate-against-east-coast-bias/23944/The Less Things Change…
https://practicaldermatology.com/columns/editors-message/the-less-things-change/23916/Currents: Dermatology Comes of Age
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-dermatology-comes-of-age/23879/The Path From Employed Provider to Owner
https://practicaldermatology.com/topics/practice-management/the-path-from-employed-provider-to-owner/23878/What to consider before owning the keys to a business.An Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.